Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 111

1.

Relationship between nutritional therapy and surgery in Crohn's disease.

Takahashi H, Ando T, Watanabe O, Maeda O, Ishiguro K, Ishikawa D, Hasegawa M, Minami M, Goto Y, Kusugami K, Ina K, Ohmiya N, Niwa Y, Goto H.

Hepatogastroenterology. 2009 Jul-Aug;56(93):1044-8.

PMID:
19760938
2.

Abnormalities in the upper gastrointestinal tract in inflammatory bowel disease.

Ando T, Nobata K, Watanabe O, Kusugami K, Maeda O, Ishiguro K, Ohmiya N, Niwa Y, Goto H.

Inflammopharmacology. 2007 Jun;15(3):101-4. Review.

PMID:
17464554
3.

Rebamipide enema therapy as a treatment for patients with active distal ulcerative colitis.

Furuta R, Ando T, Watanabe O, Maeda O, Ishiguro K, Ina K, Kusugami K, Goto H.

J Gastroenterol Hepatol. 2007 Feb;22(2):261-7.

PMID:
17295881
4.

Pit patterns in rectal mucosa assessed by magnifying colonoscope are predictive of relapse in patients with quiescent ulcerative colitis.

Nishio Y, Ando T, Maeda O, Ishiguro K, Watanabe O, Ohmiya N, Niwa Y, Kusugami K, Goto H.

Gut. 2006 Dec;55(12):1768-73. Epub 2006 May 8.

5.

Interleukin-17 levels in Helicobacter pylori-infected gastric mucosa and pathologic sequelae of colonization.

Mizuno T, Ando T, Nobata K, Tsuzuki T, Maeda O, Watanabe O, Minami M, Ina K, Kusugami K, Peek RM, Goto H.

World J Gastroenterol. 2005 Oct 28;11(40):6305-11.

6.

Disseminated intravascular coagulation associated with systemic cytomegalovirus infection during cyclosporine therapy for ulcerative colitis: report of a case.

Hibi K, Kusugami K, Ina K, Ando T, Komatsu Y, Kodera Y, Ito K, Akiyama S, Nagasaka T, Goto H, Nakao A.

Dis Colon Rectum. 2006 Jan;49(1):127-31. No abstract available.

PMID:
16328610
7.

Therapeutic efficacy of infliximab on active Crohn's disease under nutritional therapy.

Matsumoto T, Iida M, Kohgo Y, Imamura A, Kusugami K, Nakano H, Fujiyama Y, Matsu T, Hibi T.

Scand J Gastroenterol. 2005 Dec;40(12):1423-30.

PMID:
16316890
8.

Long-term follow-up after eradication of Helicobacter pylori with omeprazole, clarithromycin, and tinidazole (OCT regimen) in a Japanese population.

Ando T, Minami M, Mizuno T, Watanabe O, Ishiguro K, Ina K, Kusugami K, Nobata K, Nishiwaki T, Tsuzuki T, Shimada M, El-Omar E, Goto H.

Helicobacter. 2005 Oct;10(5):379-84.

PMID:
16181347
9.

Intestinal fibroblast-derived IL-10 increases survival of mucosal T cells by inhibiting growth factor deprivation- and Fas-mediated apoptosis.

Ina K, Kusugami K, Kawano Y, Nishiwaki T, Wen Z, Musso A, West GA, Ohta M, Goto H, Fiocchi C.

J Immunol. 2005 Aug 1;175(3):2000-9.

10.

Leukocytapheresis in ulcerative colitis: results of a multicenter double-blind prospective case-control study with sham apheresis as placebo treatment.

Sawada K, Kusugami K, Suzuki Y, Bamba T, Munakata A, Hibi T, Shimoyama T.

Am J Gastroenterol. 2005 Jun;100(6):1362-9.

PMID:
15929771
11.

[Enema therapy for ulcerative colitis patients].

Furuta R, Kusugami K, Goto H.

Nihon Rinsho. 2005 May;63(5):845-9. Review. Japanese.

PMID:
15881180
12.

A phase II multicentric trial of S-1 combined with 24 h-infusion of cisplatin in patients with advanced gastric cancer.

Iwase H, Shimada M, Tsuzuki T, Horiuchi Y, Kumada S, Haruta J, Yamaguchi T, Sugihara M, Ina K, Kusugami K, Goto S.

Anticancer Res. 2005 Mar-Apr;25(2B):1297-301.

13.
14.

[A case of gastric sarcoidosis with remarkable imaging features on multislice CT].

Suzuki T, Suzuki T, Shinoda M, Takashi H, Yamaguchi H, Miyake N, Ishikawa T, Kamiya T, Tashiro K, Kimura M, Hoshiyama M, Ina K, Ando T, Kusugami K, Goto H.

Nihon Shokakibyo Gakkai Zasshi. 2004 Dec;101(12):1340-3. Japanese. No abstract available.

PMID:
15651398
15.

Immunomodulatory therapy for inflammatory bowel disease.

Kusugami K, Ina K, Ando T, Hibi K, Nishio Y, Goto H.

J Gastroenterol. 2004 Dec;39(12):1129-37. Review.

PMID:
15622475
16.

Neutrophilic phlebitis is characteristic of intestinal Behçet's disease and simple ulcer syndrome.

Hayasaki N, Ito M, Suzuki T, Ina K, Ando T, Kusugami K, Goto H.

Histopathology. 2004 Oct;45(4):377-83.

PMID:
15469476
17.

Effect of glycine on Helicobacter pylori in vitro.

Minami M, Ando T, Hashikawa SN, Torii K, Hasegawa T, Israel DA, Ina K, Kusugami K, Goto H, Ohta M.

Antimicrob Agents Chemother. 2004 Oct;48(10):3782-8.

18.

Characteristics of Helicobacter pylori-induced gastritis and the effect of H. pylori eradication in patients with chronic idiopathic thrombocytopenic purpura.

Ando T, Tsuzuki T, Mizuno T, Minami M, Ina K, Kusugami K, Takamatsu J, Adachi K, El-Omar E, Ohta M, Goto H.

Helicobacter. 2004 Oct;9(5):443-52.

PMID:
15361084
19.

DNA typing for Helicobacter pylori isolates from eradication-failed patients: comparison of the isolates before and after therapy.

Nada T, Ando T, Nobata K, Tsuzuki T, Minami M, Ina K, Iinuma Y, Ichiyama S, Ohta M, El-Omar E, Kusugami K, Goto H.

Aliment Pharmacol Ther. 2004 Jul;20 Suppl 1:39-47.

20.

Recurrent peptic ulcers in patients following successful Helicobacter pylori eradication: a multicenter study of 4940 patients.

Miwa H, Sakaki N, Sugano K, Sekine H, Higuchi K, Uemura N, Kato M, Murakami K, Kato C, Shiotani A, Ohkusa T, Takagi A, Aoyama N, Haruma K, Okazaki K, Kusugami K, Suzuki M, Joh T, Azuma T, Yanaka A, Suzuki H, Hashimoto H, Kawai T, Sugiyama T.

Helicobacter. 2004 Feb;9(1):9-16.

PMID:
15156899
21.

Differential roles of interleukin-1beta and interleukin-8 in neutrophil transendothelial migration in patients with Helicobacter pylori infection.

Suzuki T, Ina K, Nishiwaki T, Tsuzuki T, Okada T, Furuta R, Nobata K, Ando T, Kusugami K, Goto H.

Scand J Gastroenterol. 2004 Apr;39(4):313-21.

PMID:
15125462
22.

A pilot randomized trial of a human anti-interleukin-6 receptor monoclonal antibody in active Crohn's disease.

Ito H, Takazoe M, Fukuda Y, Hibi T, Kusugami K, Andoh A, Matsumoto T, Yamamura T, Azuma J, Nishimoto N, Yoshizaki K, Shimoyama T, Kishimoto T.

Gastroenterology. 2004 Apr;126(4):989-96; discussion 947.

PMID:
15057738
23.

Plakoglobin (gamma-catenin) has TCF/LEF family-dependent transcriptional activity in beta-catenin-deficient cell line.

Maeda O, Usami N, Kondo M, Takahashi M, Goto H, Shimokata K, Kusugami K, Sekido Y.

Oncogene. 2004 Jan 29;23(4):964-72.

PMID:
14661054
24.

Concurrent chemoradiotherapy for locally advanced and metastatic esophageal cancer: longterm results of a phase II study of UFT/CDDP with radiotherapy.

Iwase H, Shimada M, Nakamura M, Nakarai K, Iyo T, Kaida S, Indo T, Kato E, Horiuchi Y, Kusugami K.

Int J Clin Oncol. 2003 Oct;8(5):305-11.

PMID:
14586756
25.

Mucosal expression of matrix metalloproteinases and their tissue inhibitors in ulcerative colitis patients.

Kusugami K, Nobata K, Tsuzuki T, Ando T, Ina K.

J Gastroenterol. 2003;38(4):412-3. No abstract available.

PMID:
12743787
26.

Enhanced somatostatin secretion into the gastric juice with recovery of basal acid output after Helicobacter pylori eradication in gastric ulcers.

Hayakawa T, Kaneko H, Konagaya T, Shinozaki K, Kasahara A, Funaki Y, Mori S, Yokoi T, Hirooka Y, Kusugami K, Kakumu S.

J Gastroenterol Hepatol. 2003 May;18(5):505-11.

PMID:
12702041
27.

Cytotoxic molecules expressed by intraepithelial lymphocytes may be involved in the pathogenesis of acute gastric mucosal lesions.

Suzuki T, Ito M, Hayasaki N, Ishihara A, Ando T, Ina K, Kusugami K.

J Gastroenterol. 2003;38(3):216-21.

PMID:
12673443
28.

Bacterial hemorrhagic enterocolitis.

Ina K, Kusugami K, Ohta M.

J Gastroenterol. 2003;38(2):111-20. Review.

PMID:
12640523
29.

Importance of medullary thyrotropin-releasing hormone in brain-gut circuits regulating gastric integrity: preclinical studies.

Kaneko H, Taché Y, Kusugami K.

J Gastroenterol. 2002 Nov;37 Suppl 14:128-32. Review.

PMID:
12572880
30.

Possible involvement of neutrophil elastase in impaired mucosal repair in patients with ulcerative colitis.

Kuno Y, Ina K, Nishiwaki T, Tsuzuki T, Shimada M, Imada A, Nishio Y, Nobata K, Suzuki T, Ando T, Hibi K, Nakao A, Yokoyama T, Yokoyama Y, Kusugami K.

J Gastroenterol. 2002 Nov;37 Suppl 14:22-32.

PMID:
12572862
31.

Evolutionary history of hrgA, which replaces the restriction gene hpyIIIR in the hpyIII locus of Helicobacter pylori.

Ando T, Aras RA, Kusugami K, Blaser MJ, Wassenaar TM.

J Bacteriol. 2003 Jan;185(1):295-301. Erratum in: J Bacteriol. 2003 Mar;185(6):2059.

32.

[Complete response in a case of advanced scirrhous type 3 gastric cancer of with bulky N2 para-aorta lymph node metastases treated by combined chemotherapy of TS-1 and CDDP].

Iwase H, Shimada M, Nakamura M, Iyo T, Nakarai K, Kaida S, Indo T, Okeya M, Mizuno T, Kusugami K, Ina K.

Gan To Kagaku Ryoho. 2002 Oct;29(10):1817-21. Japanese.

PMID:
12402436
33.

[A pilot study of TS-1 combined with cisplatin in patients with advanced gastric cancer].

Iwase H, Shimada M, Nakamura M, Iyo T, Nakarai K, Kaida S, Indo T, Okeya M, Mizuno T, Ina K, Kusugami K.

Gan To Kagaku Ryoho. 2002 Sep;29(9):1575-82. Japanese.

PMID:
12355943
34.

Lower concentrations of clarithromycin suppress urease activity, motility, and binding to gastric epithelial cells in Helicobacter pylori isolates.

Nobata K, Ina K, Ohta M, Kawamura-Sato K, Tsuzuki T, Ando T, Kusugami K.

Dig Liver Dis. 2002 Jul;34(7):489-97.

PMID:
12236482
35.

Is color Doppler ultrasonography useful for the detection of gastric varices?

Iwase H, Kusugami K.

J Gastroenterol. 2002;37(8):679-80. No abstract available.

PMID:
12203089
36.

Upregulation of mucosal soluble fas ligand and interferon-gamma may be involved in ulcerogenesis in patients with Helicobacter pylori-positive gastric ulcer.

Shimada M, Ina K, Kyokane K, Imada A, Yamaguchi H, Nishio Y, Hayakawa M, Iinuma Y, Ohta M, Ando T, Kusugami K.

Scand J Gastroenterol. 2002 May;37(5):501-11.

PMID:
12059049
37.

[Effects of H. pylori eradication on the risk factors for cardiovascular event].

Noshiro M, Ina K, Ando T, Kusugami K.

Nihon Rinsho. 2002 Feb;60 Suppl 2:769-73. Japanese. No abstract available.

PMID:
11979886
38.

[Gastric epithelial cell apoptosis and IL-18].

Shimada M, Ina K, Imada A, Nishio Y, Ando T, Kusugami K.

Nihon Rinsho. 2002 Feb;60 Suppl 2:154-8. Review. Japanese. No abstract available.

PMID:
11979769
39.

Clarithromycin increases the release of heat shock protein B from Helicobacter pylori.

Tsuzuki T, Ina K, Ohta M, Hasegawa T, Nagasaka T, Saburi N, Ueda M, Konagaya T, Kaneko H, Imada A, Nishiwaki T, Nobata K, Ando T, Kusugami K.

Aliment Pharmacol Ther. 2002 Apr;16 Suppl 2:217-28.

40.

A Helicobacter pylori restriction endonuclease-replacing gene, hrgA, is associated with gastric cancer in Asian strains.

Ando T, Wassenaar TM, Peek RM Jr, Aras RA, Tschumi AI, van Doorn LJ, Kusugami K, Blaser MJ.

Cancer Res. 2002 Apr 15;62(8):2385-9.

41.

Helicobacter pylori and gut hormones.

Kaneko H, Konagaya T, Kusugami K.

J Gastroenterol. 2002;37(2):77-86. Review.

PMID:
11871770
42.

Suppressive effects of cyclosporine A on neutrophils and T cells may be related to therapeutic benefits in patients with steroid-resistant ulcerative colitis.

Ina K, Kusugami K, Shimada M, Tsuzuki T, Nishio Y, Binion DG, Imada A, Ando T.

Inflamm Bowel Dis. 2002 Jan;8(1):1-9.

PMID:
11837932
43.

[von Recklinghausen disease associated with intrahepatic cholangiocarcinoma and ampullary carcinoid].

Takeuchi Y, Nagata K, Yokota T, Handa M, Matsunaga H, Nishio Y, Kusugami K.

Nihon Naika Gakkai Zasshi. 2001 Dec 10;90(12):2467-9. Japanese. No abstract available.

PMID:
11808180
44.

Host cell responses to genotypically similar Helicobacter pylori isolates from United States and Japan.

Ando T, Peek RM Jr, Lee YC, Krishna U, Kusugami K, Blaser MJ.

Clin Diagn Lab Immunol. 2002 Jan;9(1):167-75.

45.

Polymorphisms of Helicobacter pylori HP0638 reflect geographic origin and correlate with cagA status.

Ando T, Peek RM, Pride D, Levine SM, Takata T, Lee YC, Kusugami K, van der Ende A, Kuipers EJ, Kusters JG, Blaser MJ.

J Clin Microbiol. 2002 Jan;40(1):239-46.

46.

Syndecan-4 deficiency leads to high mortality of lipopolysaccharide-injected mice.

Ishiguro K, Kadomatsu K, Kojima T, Muramatsu H, Iwase M, Yoshikai Y, Yanada M, Yamamoto K, Matsushita T, Nishimura M, Kusugami K, Saito H, Muramatsu T.

J Biol Chem. 2001 Dec 14;276(50):47483-8. Epub 2001 Oct 3.

47.

Pneumatosis cystoides intestinalis treated with hyperbaric oxygen therapy: usefulness of an endoscopic ultrasonic catheter probe for diagnosis.

Shimada M, Ina K, Takahashi H, Horiuchi Y, Imada A, Nishio Y, Ando T, Kusugami K.

Intern Med. 2001 Sep;40(9):896-900. Review.

48.

Troxipide, a novel antiulcer compound, has inhibitory effects on human neutrophil migration and activation induced by various stimulants.

Kusugami K, Ina K, Hosokawa T, Kobayashi F, Kusajima H, Momo K, Nishio Y.

Dig Liver Dis. 2000 May;32(4):305-11.

PMID:
11515628
49.

Coordinate upregulation of interleukin-8 and growth-related gene product-alpha is present in the colonic mucosa of inflammatory bowel.

Imada A, Ina K, Shimada M, Yokoyama T, Yokoyama Y, Nishio Y, Yamaguchi T, Ando T, Kusugami K.

Scand J Gastroenterol. 2001 Aug;36(8):854-64.

PMID:
11495082
50.

Interactions among gastric somatostatin, interleukin-8 and mucosal inflammation in Helicobacter pylori-positive peptic ulcer patients.

Yamamoto S, Kaneko H, Konagaya T, Mori S, Kotera H, Hayakawa T, Yamaguchi C, Uruma M, Kusugami K, Mitsuma T.

Helicobacter. 2001 Jun;6(2):136-45.

PMID:
11422469

Supplemental Content

Loading ...
Support Center